sr141716 has been researched along with oxyntomodulin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloom, SR; Dhillo, WS; Gardiner, JV; Ghatei, MA; Kennett, GA; Liu, YL; Small, CJ; White, NE | 1 |
| Al-Zaman, Y; Aylwin, S | 1 |
1 review(s) available for sr141716 and oxyntomodulin
| Article | Year |
|---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
1 other study(ies) available for sr141716 and oxyntomodulin
| Article | Year |
|---|---|
Co-administration of SR141716 with peptide YY3-36 or oxyntomodulin has additive effects on food intake in mice.
Topics: Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eating; Fasting; Mice; Obesity; Oxyntomodulin; Peptide Fragments; Peptide YY; Piperidines; Pyrazoles; Rimonabant; Treatment Outcome | 2008 |